Yuhan (XKRX:000100) FCF Margin % : -3.84% (As of Mar. 2024)

View and export this data going back to 1962. Start your Free Trial

What is Yuhan FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Yuhan's Free Cash Flow for the three months ended in Mar. 2024 was ₩-17,093 Mil. Yuhan's Revenue for the three months ended in Mar. 2024 was ₩444,593 Mil. Therefore, Yuhan's FCF Margin % for the quarter that ended in Mar. 2024 was -3.84%.

As of today, Yuhan's current FCF Yield % is -1.37%.

The historical rank and industry rank for Yuhan's FCF Margin % or its related term are showing as below:

XKRX:000100' s FCF Margin % Range Over the Past 10 Years
Min: -4.34 Med: 1.16 Max: 5.5
Current: -4.34

During the past 13 years, the highest FCF Margin % of Yuhan was 5.50%. The lowest was -4.34%. And the median was 1.16%.

XKRX:000100's FCF Margin % is ranked worse than
60.49% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 0.16 vs XKRX:000100: -4.34

Yuhan FCF Margin % Historical Data

The historical data trend for Yuhan's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan FCF Margin % Chart

Yuhan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

1.30

-3.85

1.01

0.29

-3.22

Yuhan Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															0.86	-5.31	-6.70	-1.15	-3.84

Competitive Comparison of Yuhan's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yuhan's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Yuhan's FCF Margin % falls into.

Yuhan FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Yuhan's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-59927.115	/	1858983.76
	=	-3.22 %

Yuhan's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-17092.92	/	444593.458
	=	-3.84 %

Yuhan FCF Margin % Related Terms

Thank you for viewing the detailed overview of Yuhan's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuhan (XKRX:000100) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » FCF Margin %

Traded in Other Exchanges

000105:Korea

Address

74, Noryangjin-ro, Dongjak-gu, Seoul, KOR

Website

http://www.yuhan.co.kr

Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines